Volume 26, Issue 119 (November & December 2018)                   J Adv Med Biomed Res 2018, 26(119): 1-5 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Pezeshkpoor F, Zabolinejad N, Golnouri F, Torabi S, Abed J. Quality of Life in Psoriasis Patients and Its Correlation with Disease Severity. J Adv Med Biomed Res. 2018; 26 (119) :1-5
URL: http://zums.ac.ir/journal/article-1-5751-en.html
Cutaneous Leishmaniasis Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
Abstract:   (185 Views)
Background & Objective:  Psoriasis is a chronic and relapsing disease with a prevalence of 2%. Since it is a chronic and non-fatal skin disease, its impact on quality of life in patients is underestimated compared to other diseases. This study points out to the importance of the quality of life in these patients and their correlation with disease severity.
Materials & Methods:  Quality of life of psoriasis patients was assessed by using the Dermatology Life Quality Index (DLQI) and psoriasis severity was measured, using Psoriasis Area Severity Index (PASI). DLQI were compared regarding age, gender and affected areas in patients.
Results:  Among 135 patients, 67 (49.6%) were male and 68 (50.4%) were female. The mean age of subjects was 41.49±15.43 years (ranging from 17 to 83 years). The mean DLQI score was 10.73±7.3 (ranging from 0 to 26). Independent t-test showed that the mean DLQI score was significantly greater in women than men (P=0.031) Spearman test showed positive correlation between DLQI and age as well as PASI and DLQI.
Conclusion:  Results of this study showed a positive and significant correlation between PASI score and quality of life of patients, which implies that with increasing the severity of the disease, the effect of psoriasis on patients' quality of life increases as well.
Full-Text [PDF 267 kb]   (86 Downloads) |   |   Full-Text (HTML)  (13 Views)  

✅ Results of this study showed a positive and significant correlation between PASI score and quality of life of patients, which implies that with increasing the severity of the disease, the effect of psoriasis on patients' quality of life increases as well.
Type of Study: Original | Subject: Clinical medicine
Received: 2019/08/17 | Accepted: 2019/08/17 | Published: 2019/08/17

References
1. Böhm D, Stock Gissendanner S, Bangemann K, et al. Perceived relationships between severity of psoriasis symptoms, gender, stigmatization and quality of life. J Eur Acad Dermatol Venereol. 2013; 27(2): 220-6. [DOI:10.1111/j.1468-3083.2012.04451.x] [PMID]
2. Schöffski O, Augustin M, Prinz J, et al. Costs and quality of life in patients with moderate to severe plaque‐type psoriasis in Germany: A multi‐center study. J Dtsch Dermatol Ges. 2007; 5(3): 209-18 [DOI:10.1111/j.1610-0387.2007.06240.x] [PMID]
3. Feldman S, Pearce D. Epidemiology, clinical manifestations, and diagnosis of psoriasis. UpToDate, Waltham. 2013.
4. De Korte J, Mombers FM, Bos JD, Sprangers MA. Quality of life in patients with psoriasis: a systematic literature review. J Invest Dermatol Symposium Proceedings. 2004: 9(2): 140-7. [DOI:10.1046/j.1087-0024.2003.09110.x] [PMID]
5. Choi J, Koo JY. Quality of life issues in psoriasis. J Am Acad Dermatol. 2003; 49(2): 57-61. [DOI:10.1016/S0190-9622(03)01136-8]
6. Mease PJ, Menter MA. Quality-of-life issues in psoriasis and psoriatic arthritis: outcome measures and therapies from a dermatological perspective. J Am Acad Dermatol. 2006; 54(5): 685-704. [DOI:10.1016/j.jaad.2005.10.008] [PMID]
7. Bhosle MJ, Kulkarni A, Feldman SR, Balkrishnan R. Quality of life in patients with psoriasis. Health Qual Life Outcomes. 2006; 4: 35. [DOI:10.1186/1477-7525-4-35] [PMID] [PMCID]
8. Rapp SR, Feldman SR, Exum ML, et al. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999; 41: 401-7. [DOI:10.1016/S0190-9622(99)70112-X]
9. Krueger G, Koo J, Lebwohl M, et al. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol. 2001; 137(3): 280-4.
10. Martínez-García E, Arias-Santiago S, Valenzuela-Salas I, et al. Quality of life in persons living with psoriasis patients. J Am Acad Dermatol. 2014; 71(2): 302-7. [DOI:10.1016/j.jaad.2014.03.039] [PMID]
11. Aghaei S, Moradi A, Ardekani GS. Impact of psoriasis on quality of life in Iran. Indian J Dermatol Venereol Leprol. 2009; 75(2): 220. [DOI:10.4103/0378-6323.48689] [PMID]
12. Abedini R, Lajevardi V, Hallaji Z , Khodashenas Z, Zafar F, Nasimi M. Quality of life in patients with psoriasis: A cross-sectional study in a dermatology referral hospital in Tehran, Iran. Iran J Dermatol. 2016; 19(4): 113-18.
13. Zandi S, Shamsi S, Hashemi S, Saburi F. Evaluation of quality of life in patients with psoriasis. J Dermatol and Cosmetetic. 2011; 2(3): 166-73.
14. Finlay AY, Khan G. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Experiment dermatol. 1994; 19(3): 210-6. [DOI:10.1111/j.1365-2230.1994.tb01167.x]
15. Feldman SR, Fleischer AB, Reboussin DM, et al. The self-administered psoriasis area and severity index is valid and reliable. J Invest Dermatol. 1996; 106(1): 183-6. [DOI:10.1111/1523-1747.ep12329912] [PMID]
16. Aghaei S, Sodaifi M, Jafari P, et al. DLQI scores in vitiligo: reliability and validity of the Persian version. BMC Dermatol. 2004; 4: 8. [DOI:10.1186/1471-5945-4-8] [PMID] [PMCID]
17. Mabuchi T, Yamaoka H, Kojima T, et al. Psoriasis affects patient's quality of life more seriously in female than in male in Japan. Tokai J Exp Clin Med. 2012; 37(3): 84-8.
18. Gelfand JM, Feldman SR, Stern RS, et al. Determinants of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol. 2004; 51(5): 704-8. [DOI:10.1016/j.jaad.2004.04.014] [PMID]
19. Sampogna F, Chren M, Melchi C, et al. Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis. Br J Dermatol. 2006; 154(2): 325-31. [DOI:10.1111/j.1365-2133.2005.06909.x] [PMID]
20. Lin TY, See LC, Shen YM, et al. Quality of life in patients with psoriasis in northern Taiwan. Chang Gung Med J. 2011; 34(2): 186-96.
21. Lundberg L, Johannesson M, Silverdahl M, et al. Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity. Acta Dermatovenereologica-Stockholm. 2000; 80(6): 430-4 [DOI:10.1080/000155500300012873] [PMID]
22. Mattei PL, Corey K, Kimball A. Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies. J Eur Acad Dermatol Venereol. 2014; 28(3): 333-7. [DOI:10.1111/jdv.12106] [PMID]
23. Rencz F, Poór AK, Péntek M. A detailed analysis of 'not relevant' responses on the DLQI in psoriasis: potential biases in treatment decisions. J Eur Acad Dermatol Venereol. 2018; 32(5): 783-90. doi: 10.1111/jdv.14676. [DOI:10.1111/jdv.14676] [PMID]
24. Rencz F, Gulácsi L, Péntek M. Proposal of a new scoring formula for the DLQI in psoriasis. Br J Dermatol. 2018; 179(5): 1102-108. https://doi.org/10.1111/bjd.16927 [DOI:10.1111/bjd.17214] [PMID]

Add your comments about this article : Your username or Email:
CAPTCHA

© 2019 All Rights Reserved | J Adv Med Biomed Res

Designed & Developed by : Yektaweb  Co-Publisher: Farname Inc.